VYGR
Price
$4.98
Change
+$0.09 (+1.84%)
Updated
Oct 14 closing price
Capitalization
276.51M
34 days until earnings call
Intraday Buy/Sell Signals
XNCR
Price
$12.43
Change
-$1.53 (-10.96%)
Updated
Oct 14 closing price
Capitalization
885.83M
26 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

VYGR vs XNCR

Header iconVYGR vs XNCR Comparison
Open Charts VYGR vs XNCRBanner chart's image
Voyager Therapeutics
Price$4.98
Change+$0.09 (+1.84%)
Volume$567.55K
Capitalization276.51M
Xencor
Price$12.43
Change-$1.53 (-10.96%)
Volume$2.9M
Capitalization885.83M
VYGR vs XNCR Comparison Chart in %
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VYGR vs. XNCR commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VYGR is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (VYGR: $4.98 vs. XNCR: $12.43)
Brand notoriety: VYGR and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VYGR: 76% vs. XNCR: 280%
Market capitalization -- VYGR: $276.51M vs. XNCR: $885.83M
VYGR [@Biotechnology] is valued at $276.51M. XNCR’s [@Biotechnology] market capitalization is $885.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VYGR’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • VYGR’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VYGR’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 3 bullish TA indicator(s).

  • VYGR’s TA Score: 4 bullish, 4 bearish.
  • XNCR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than XNCR.

Price Growth

VYGR (@Biotechnology) experienced а +5.29% price change this week, while XNCR (@Biotechnology) price change was +3.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

VYGR is expected to report earnings on Nov 18, 2025.

XNCR is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($886M) has a higher market cap than VYGR($277M). VYGR YTD gains are higher at: -12.169 vs. XNCR (-45.909). VYGR has higher annual earnings (EBITDA): -119.18M vs. XNCR (-125.38M). XNCR has more cash in the bank: 444M vs. VYGR (43.9M). VYGR has less debt than XNCR: VYGR (40.2M) vs XNCR (67.9M). XNCR has higher revenues than VYGR: XNCR (147M) vs VYGR (42.6M).
VYGRXNCRVYGR / XNCR
Capitalization277M886M31%
EBITDA-119.18M-125.38M95%
Gain YTD-12.169-45.90927%
P/E Ratio6.32N/A-
Revenue42.6M147M29%
Total Cash43.9M444M10%
Total Debt40.2M67.9M59%
FUNDAMENTALS RATINGS
VYGR vs XNCR: Fundamental Ratings
VYGR
XNCR
OUTLOOK RATING
1..100
2126
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
4240
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
9075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (46) in the Biotechnology industry is somewhat better than the same rating for XNCR (85). This means that VYGR’s stock grew somewhat faster than XNCR’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as XNCR (100). This means that VYGR’s stock grew similarly to XNCR’s over the last 12 months.

VYGR's SMR Rating (97) in the Biotechnology industry is in the same range as XNCR (97). This means that VYGR’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's Price Growth Rating (40) in the Biotechnology industry is in the same range as VYGR (42). This means that XNCR’s stock grew similarly to VYGR’s over the last 12 months.

XNCR's P/E Growth Rating (5) in the Biotechnology industry is in the same range as VYGR (8). This means that XNCR’s stock grew similarly to VYGR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VYGRXNCR
RSI
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 8 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 8 days ago
84%
Momentum
ODDS (%)
Bullish Trend 8 days ago
79%
N/A
MACD
ODDS (%)
Bullish Trend 8 days ago
84%
N/A
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 8 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 8 days ago
72%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 8 days ago
71%
Declines
ODDS (%)
Bearish Trend 23 days ago
85%
Bearish Trend 13 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
74%
Aroon
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 8 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STMSX24.400.30
+1.24%
SEI Tax-Managed Small/Mid Cap F (SIMT)
CRVRX7.980.09
+1.14%
NYLI CBRE Real Estate Fund Investor Cl
AISHX6.030.06
+1.01%
Aristotle Small/Mid Cap Equity C
NRACX50.640.08
+0.16%
Neuberger Berman Quality Equity C
FSSKX90.11N/A
N/A
Fidelity Stock Selec-Class K

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+1.84%
RGNX - VYGR
52%
Loosely correlated
-0.79%
KYMR - VYGR
51%
Loosely correlated
-2.72%
XNCR - VYGR
49%
Loosely correlated
-10.96%
TRDA - VYGR
49%
Loosely correlated
+4.30%
NRIX - VYGR
49%
Loosely correlated
-5.56%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-10.96%
CRNX - XNCR
62%
Loosely correlated
-0.86%
DYN - XNCR
58%
Loosely correlated
+10.12%
NUVL - XNCR
56%
Loosely correlated
-5.67%
SYRE - XNCR
56%
Loosely correlated
+11.02%
ERAS - XNCR
56%
Loosely correlated
+0.42%
More